Krishna Datla, Promoter and MD of Fermenta Biotech announced the appointment of CEO, Prashant Nagre, as the new MD with effect from May 9, 2021. Datla will continue as a Board member and the Executive Vice Chairman.
The initiative will be a part of the Joint Corporate Social Responsibility programme of Fermenta, India’s only manufacturer of Vitamin D3 and a leading player globally along with Indchemie.